entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 12:53:45 - browse：83636

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Can medical device makers keep up in the race to treat obesity?

focus

WSS

New oral drug delivery patch is modeled after octopus tentacles

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Biogen nominates mother of director’s child to replace him on board

Inside the rise of 'mukbang' eating videos

Living organ donors deserve priority status for transplants

Inside the rise of 'mukbang' eating videos

focus

entertainment

focus

Medicare proposal to cover medical devices draws a mixed reaction

Medicare innovation center doesn’t save money, experts say

Tori Bowie and the unacceptable rates of Black maternal death

Lawsuit highlights wrinkle for disputes over surprise medical bills

Apple is now the first public company to be valued at $3 trillion

CRISPR base editing slashes cholesterol levels in monkeys

Jerome Adams on the need for new antivirals for Covid

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

In Memoriam: Notable people who died in 2023

Stop Congress from blocking public access to science

knowledge

Biden administration plans revamp of organ transplant system

Medicare innovation center doesn’t save money, experts say

Study points to new risk in gene therapy death of Terry Horgan

Setback for rare diseases as Taysha Gene Therapies pulls back

Sea level rise could wash away turtle breeding grounds around the world, researchers say

2023 Nobel Prize in Medicine goes to Karikó and Weissman

focus

hotspot

hotspot

hotspot